Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
AAO News
Repka Plans to Use AAO Presidency to Push for Medicare Payment Reform
Michael X. Repka, MD, MBA, the new president of the American Academy of Ophthalmology, plans to make Medicare payment reform his top priority during his one-year term. Medicare reimbursement to US ...
Gene Therapies Make Progress Toward Goal of Restoring Sight
Gene therapies again generated buzz at the 2024 AAO meeting—as they have at recent meetings—but perhaps most exciting were reports of a treatment that could partially restore severe vision loss fro...
Zeiss Bolsters Launch of Micor 700 at AAO Meeting With US Surgeons Discussing Adoption
Carl Zeiss Meditec featured its Micor 700 at the 2024 meeting of the American Academy of Ophthalmology in Chicago, Illinois, with presentations that included booth talks by select US surgeons who h...
Ophthalmology Continues to Draw Investors, Eyecelerator Meeting Shows; Retina Stands Out
Ophthalmology remains an appealing investment, driven largely by procedural growth. While hundreds of companies are working toward technology enhancements and innovative therapies, ophthalmology pr...
AI Discussions Surge at Eye Meetings with Aim to Allay Fears, Seek Use Cases
The explosive growth of artificial intelligence has generated both fear and excitement among many in the ophthalmic industry. As technology progresses, so do the conversations at major meetings, wi...
Office-Based Surgery Garners Enthusiasm at 2024 AAO Meeting
Several sessions at the 2024 American Academy of Ophthalmology meeting highlighted the trend of office-based surgery (OBS) and the option of oral sedation among practitioners. The consensus among t...
AAO Puts FDA Deputy Director of Ophthalmology on the Hot Seat
William Boyd, MD, deputy director of ophthalmology at the US FDA’s Office of New Drugs, had a quick answer when asked to name the biggest unmet need in ophthalmology. “We need and want more therapi...
Are Drugs for GA in the ‘Trough of Disillusionment’?
The celebrations and excitement that accompanied the launch in 2023 of the first two drugs approved in the US for the treatment geographic atrophy (GA) gave way to a hangover and regrets at the 202...
Weighing the Ophthalmic Impact of Boom in GLP-1 Receptor Agonist Treatment
Recent studies indicate that up to 6 percent of the US population is currently taking a GLP-1 receptor agonist, a class of drugs prescribed to help manage blood glucose levels for diabetes and weig...
New Trifocal IOLs Expected to Help the US Resume PC-IOL Growth
Bausch + Lomb’s enVista Envy and J&J Vision’s Odyssey are two new trifocal IOLs that were shown at the 2024 AAO meeting in Chicago. They are expected to help reverse the decline in trifocal IOL sal...
AAO and Eyecelerator Sessions Showcase Latest in Glaucoma Lasers and Surgical Devices
New glaucoma lasers and surgical devices were shown at various venues during the 2024 AAO meeting, including Glaucoma Subspecialty Day and the Eyecelerator meeting. There was also an important upda...
Alcon Looks to Refine Retinal Surgery with Unifeye, Unipexy
Alcon launched at the 2024 AAO meeting two new retinal surgical devices—Unifeye for air-gas exchange and Unipexy for retinopexy. Each is a one-person, hand-held, single-use gas delivery device. The...
Cornea and Eye Banking Forum Looks at Ways to Expand the Donor Pool
Expanding the donor pool was once again top of mind at the 2024 Cornea and Eye Banking Forum, held Oct. 18 in conjunction with the AAO meeting in Chicago, Illinois. The forum, supported by the Eye ...
AAO and Eyenuk Collaborate on AI-Driven DR Screening for Underserved Patients
Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...
Eyenuk, AAO Collaborate to Offer AI-Driven DR Screening for Underserved Patients in Delaware
Eyenuk and the American Academy of Ophthalmology (AAO) reported Oct. 16 that they had teamed up under the AAO’s EyeCare America program to provide eye disease screening for underserved communities ...
Meet with Market Scope at the 2024 AAO Meeting
Market Scope will be exhibiting at the 2024 AAO meeting, set for Oct. 18-21 at McCormick Place in Chicago. We will be located at Booth 4903. Contact us to set up a time to discuss any custom resear...
AAO Glaucoma Day Session Evaluates Latest Devices Advancing or Sold Outside the US
US glaucoma specialists have over 20 surgical options to treat their patients, but even more devices are available or in the pipeline outside the US, and their developers could seek FDA approval. M...
Retina Specialists Face Complement Inhibition Therapy with Mixed Emotions
The use of complement inhibitors to slow the progression of geographic atrophy (GA) is shaping up as the fulcrum for changing how ophthalmologists deliver and get compensated for retina care. Two c...
Pros and Cons of Same-Day Cataract Surgery Debated During AAO Refractive Day
The advantages and disadvantages of immediate sequential bilateral cataract surgery (ISBCS) took center stage during a 2023 AAO Refractive Day session that tasked Rupert Menapace, MD (Austria), wit...
US Refractive Surgeons Grapple with Treatment Options for High Myopes
Surgeons attending the Refractive Subspecialty Day at the 2023 AAO meeting in San Francisco debated the ideal treatment options for patients with moderate to high myopia. Practices shared widely di...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.